Bristol-Myers Squibb Past Earnings image   This BMY past earnings page last updated 10/29/2021
Bristol-Myers Squibb Past Earnings
Data adjusted for BMY split history

PeriodPast Earnings DateAdj. EPS
Q3 202110/27/20212.000
Q2 20217/28/20211.930
Q1 20214/29/20211.740
Q4 20202/4/20211.460
Q3 202011/5/20201.630
Q2 20208/6/20201.630
Q1 20205/7/20201.720
Q4 20192/6/20201.220
Q3 201910/31/20191.170
Q2 20197/25/20191.180
Q1 20194/25/20191.100
Q4 20181/24/20190.94
Q3 201810/25/20181.09
Q2 20187/26/20181.01
Q1 20184/26/20180.94
Q4 20172/5/20180.68
Q3 201710/26/20170.75
Q2 20177/27/20170.74
Q1 20174/27/20170.84
Q4 20161/26/20170.63
Q3 201610/27/20160.77
Q2 20167/28/20160.69
Q1 20164/28/20160.74
Q4 20151/28/20160.38
Q3 201510/27/20150.39
Q2 20157/23/20150.53
Q1 20154/28/20150.71
Q4 20141/27/20150.46
Q3 201410/24/20140.45
Q2 20147/24/20140.48
Q1 20144/29/20140.46
Q4 20131/24/20140.51
Q3 201310/23/20130.46
Q2 20137/25/20130.44
Q1 20134/25/20130.41
Q4 20121/24/20130.47
Q3 201210/24/20120.41
Q2 20127/25/20120.48
Q1 20124/25/20120.64
Bristol-Myers Squibb Past Revenue
PeriodPast Earnings DateGAAP
Q3 202110/27/202111.62B
Q2 20217/28/202111.70B
Q1 20214/29/202111.07B
Q4 20202/4/202111.07B
Q3 202011/5/202010.54B
Q2 20208/6/202010.13B
Q1 20205/7/202010.78B
Q4 20192/6/20207.95B
Q3 201910/31/20196.01B
Q2 20197/25/20196.27B
Q1 20194/25/20195.92B
Q4 20181/24/20195.97B
Q3 201810/25/20185.69B
Q2 20187/26/20185.70B
Q1 20184/26/20185.19B
Q4 20172/5/20185.45B
Q3 201710/26/20175.25B
Q2 20177/27/20175.14B
Q1 20174/27/20174.93B
Q4 20161/26/20175.24B
Q3 201610/27/20164.92B
Q2 20167/28/20164.87B
Q1 20164/28/20164.39B
Q4 20151/28/20164.29B
Q3 201510/27/20154.07B
Q2 20157/23/20154.16B
Q1 20154/28/20154.04B
Q4 20141/27/20154.26B
Q3 201410/24/20143.92B
Q2 20147/24/20143.89B
Q1 20144/29/20143.81B
Q4 20131/24/20144.44B
Q3 201310/23/20134.07B
Q2 20137/25/20134.05B
Q1 20134/25/20133.83B
Q4 20121/24/20134.20B
Q3 201210/24/20123.74B
Q2 20127/25/20124.44B
Q1 20124/25/20125.25B
Quotes delayed 20 minutes

Email EnvelopeFree BMY Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts
10 Most Oversold S&P 500 Stocks
10 Most Overbought S&P 500 Stocks
10 ETFs With Stocks Insiders Are Buying
10 ETFs With Most Upside To Targets
The DividendRank Top 25
Warren Buffett Dividend Stocks
10 Cheap Dividend Stocks Under $10
10 Top DividendRank'ed Energy Stocks
The 10 Highest Yielding Preferred Stocks
The 10 Highest Yielding Preferred Stocks
The 15 Most Active S&P Call & Put Options
Bristol-Myers Squibb (BMY) is categorized under the Healthcare sector; to help you further research past earnings across stocks, below are some other companies in the same sector:

BNGO Historical Earnings
BOLT Historical Earnings
BPMC Historical Earnings
BPTH Historical Earnings
BRKR Historical Earnings
BSGM Historical Earnings
BSX Historical Earnings
BTAI Historical Earnings
BVS Historical Earnings
BXRX Historical Earnings

BMY Past Earnings Q&A

What was the best and worst BMY past earnings results?
For Bristol-Myers Squibb, I'm wondering what the company's very best and worst earnings results have been, on an earnings per share basis?

✔️Accepted answer: The highest BMY past earnings result in our data set was 2.000/share posted in Q3 2021, while the lowest was in Q4 2015 when BMY posted 0.38/share.

  Suggested answer: The biggest top line earnings performance — aka revenue — quarter was in Q2 2021 when BMY reported 11.70B in revenue, while the quarter with the lowest revenue in our data set was Q3 2012 at 3.74B of revenue.

  Suggested answer: There are 39 BMY past earnings results in our data set.

On this page we presented the BMY past earnings date information for Bristol-Myers Squibb. Reviewing that Bristol-Myers Squibb Past Earnings for the company, we see that the highest past earnings result in our data set was in Q3 2021, when BMY posted adjusted EPS of 2.000/share. Meanwhile the lowest BMY past earnings result was in Q4 2015, when BMY posted adjusted EPS of 0.38/share. Turning to top line revenue performance, the biggest revenue quarter in our data set was seen in Q2 2021 when BMY reported 11.70B in revenue, while the smallest revenue quarter was Q3 2012 when BMY reported 3.74B in revenue.

Any self directed investor doing their due diligence on BMY or any other given stock can benefit from researching all of the Bristol-Myers Squibb past earnings — and here, we present each quarter's result all together on one page for easy comparison. Studying this information can help when projecting future earnings, as well as determining whether the past earnings trajectory justifies the current stock value. That's why we bring you PastEarnings.com to make it easy for investors to investigate Bristol-Myers Squibb past earnings, or the past earnings information for any stock in our coverage universe. And in your continued research we hope you will be sure to check out the further links included for earnings surprises history (beat/miss data) as well as next earnings dates for BMY. Thanks for visiting, and the next time you need to research BMY past earnings or those of another stock, we hope you'll think of our site, as your go-to past earnings research resource of choice.
 

Bristol-Myers Squibb Past Earnings | www.PastEarnings.com | Copyright © 2020 - 2021, All Rights Reserved

Nothing in PastEarnings.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.